4D Molecular Therapeutics FDMT Q1 2025 earnings
Reported May 8, 2025 · Before market open
Revenue$14.0KMiss by $523.5K
EPS-$0.86Miss by $0.02
Revenue estimate$537.5K
EPS estimate-$0.84
Next report
Aug 10, 2026 (In 1 week)Revenue estimate$3.7M
EPS estimate-$1.04
Financials
Q1 2025Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
Ask the moment 4D Molecular Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did 4D Molecular Therapeutics report Q1 2025 earnings?
- 4D Molecular Therapeutics (FDMT) reported Q1 2025 earnings on May 8, 2025 before market open.
- What were 4D Molecular Therapeutics's Q1 2025 revenue and EPS?
- 4D Molecular Therapeutics reported revenue of $14.0K and eps of $-0.86 for Q1 2025.
- Did 4D Molecular Therapeutics beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $537.5K by $523.5K. EPS missed the consensus estimate of $-0.84 by $0.02.
- How did 4D Molecular Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 50.0% from $28.0K a year earlier and eps declined 30.3% from $-0.66.
- Where can I find 4D Molecular Therapeutics's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-067040) directly on SEC EDGAR. The filing index links above go to sec.gov.